Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
A conversation with Impulse Space’s Tom Mueller and Hadrian’s Chris Power.
The story you hear nowadays is that America is struggling to make things and can’t compete with China when it comes to advanced manufacturing. But of course, there’s tons of high-tech stuff being produced in the US, and more and more companies are doing it out of Southern California, with factories sprouting up around Los Angeles to build things like precision metal parts and jet engines. Two founders who are actively engaged in building things in LA are Tom Mueller, founder of Impulse Space (an
Societe Generale lifted its profitability target as CEO Slawomir Krupa aims to cut costs and boost investor payouts with a new strategy. The French lender increased the goal for its return on tangible equity to between 13% and 14% in 2029 and to more than 15% after that, according to a statement Monday. Bloomberg’s Tom Metcalf reports. (Source: Bloomberg)
Sharon Bell, equity strategist at Goldman Sachs, discusses the selloff in bonds and why she’s positive on European equities. “15% earnings growth is pretty impressive,” Bell tells Bloomberg Television. “European companies are global in their reach. They have a lot of exposure to lots of things you want at the moment,” she adds. (Source: Bloomberg)
Turkey froze assets tied to executives at several investment firms, expanding an investigation into a fund-industry crisis that has already triggered redemption failures, arrests and a sharp selloff in stocks.
Anna Edwards, Guy Johnson, Tom Mackenzie and Mark Cudmore break down today’s key themes for analysts and investors on “Bloomberg: The Opening Trade.” (Source: Bloomberg)